1 October 2011

Contents

Conference reports

• 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 17-20 July 2011, Rome

• Cure research and viral reservoirs

• Orange Farm circumcision results dispel concerns about risk compensation

• Randomised trial of ART in TB patients with high CD4 counts

Antiretrovirals

• Once-daily nevirapine approved in Europe

• Fixed-dose combination of rilpivirine/tenofovir/FTC (Eviplera) recommended for approval in Europe

• ViiV withdraw European application for once-daily maraviroc

Treatment access

• FDA approval of generic ARVs

• Global Fund adopts restructuring recommendations and close to 50% funding shortfall for next round of grants

Pregnancy

• Increased risk of preterm delivery with protease inhibitor based HAART in Mma Bana

• Efavirenz in pregnancy: update of systemic review and meta-analysis

• AZT not equivalent to HAART to prevent mother-to-child transmission in a Botswana programme

• Increased risk of HIV transmission to HIV negative partners during pregnancy

Paediatric care

• Pharmacokinetics of paediatric tenofovir based regimens

• Atazanavir pharmacokinetics in infants, children and adolescents

• Crushing lopinavir/ritonavir tablets decreases exposure by almost half in children

TB coinfection

• WHO Guidelines on guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

• IPT for adults: Should the Mantoux test have been removed from WHO guidelines?

HIV prevention and transmission

• DSMB stops oral tenofovir monotherapy arm of VOICE PrEP study due to lack of difference compared to placebo

Other news

• i-Base phoneline and information request services: review of service use: 2004-2011

Job vacancies

• Job vacancy: i-Base administrator

PDFs

• Volume 12 Number 9/10 September/October 2011 PDF